These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21517236)

  • 41. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
    Sergentanis TN; Economopoulos KP
    Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
    Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
    Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.
    Huang M; Spitz MR; Gu J; Lee JJ; Lin J; Lippman SM; Wu X
    Carcinogenesis; 2006 Oct; 27(10):2034-7. PubMed ID: 16638786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a meta-analysis.
    Li M; Dai W; Zhou H
    ScientificWorldJournal; 2013; 2013():689048. PubMed ID: 24222746
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The CCND1 G870A gene polymorphism and brain tumor risk: a meta-analysis.
    Qin LY; Zhao LG; Chen X; Li P; Yang Z; Mo WN
    Asian Pac J Cancer Prev; 2014; 15(8):3607-12. PubMed ID: 24870765
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of cyclin D1 (CCND1) and E-cadherin (CDH1) alterations to colorectal cancer susceptibility: a case-control study.
    Govatati S; Singamsetty GK; Nallabelli N; Malempati S; Rao PS; Madamchetty VK; Govatati S; Kanapuram R; Narayana N; Bhanoori M; Kassetty K; Nallanchakravarthula V
    Tumour Biol; 2014 Dec; 35(12):12059-67. PubMed ID: 25146682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk.
    Liu B; Zhang Y; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
    Mol Carcinog; 2010 Jan; 49(1):75-84. PubMed ID: 19795398
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GG genotype of cyclin D1 G870A polymorphism is associated with non-cardiac gastric cancer in a high-risk region of China.
    Jia A; Gong J; Li Y; Hao Z; Chang X; Dai F; Yu B
    Scand J Gastroenterol; 2008; 43(11):1353-9. PubMed ID: 18609126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.
    Cai W; Wang ZT; Zhong J; Zhang Y
    Genet Mol Res; 2013 Apr; 12(4):6636-45. PubMed ID: 23661400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
    Yang SM; Shi YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
    Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between cyclin D1 (CCND1) polymorphism and gastric cancer risk in Japanese population.
    Tahara T; Arisawa T; Shibata T; Yamashita H; Hirata I
    Hepatogastroenterology; 2009; 56(93):1232-5. PubMed ID: 19760977
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas.
    Lewis RC; Bostick RM; Xie D; Deng Z; Wargovich MJ; Fina MF; Roufail WM; Geisinger KR
    Cancer Res; 2003 Dec; 63(23):8549-53. PubMed ID: 14679024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of cyclin D1 variants with head and neck cancer susceptibility: evidence from a meta-analysis.
    Lin H; Fang L; Lin D
    Asian Pac J Cancer Prev; 2014; 15(14):5645-51. PubMed ID: 25081680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A MLH1 polymorphism that increases cancer risk is associated with better outcome in sporadic colorectal cancer.
    Nejda N; Iglesias D; Moreno Azcoita M; Medina Arana V; González-Aguilera JJ; Fernández-Peralta AM
    Cancer Genet Cytogenet; 2009 Sep; 193(2):71-7. PubMed ID: 19665066
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CCND1 G870A polymorphism with altered cyclin D1 transcripts expression is associated with the risk of glioma in a Chinese population.
    Chen X; Zhao T; Li L; Xu C; Zhang X; Tse V; Zhang T; Liu X; Lu F
    DNA Cell Biol; 2012 Jun; 31(6):1107-13. PubMed ID: 22304571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
    Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cyclin D1 (CCND1) G870A polymorphism and lung cancer susceptibility: a meta-analysis.
    Zhou C; An H; Hu M; Liu Q; Geng P; Xu J; Sun B; Liu C
    Tumour Biol; 2013 Dec; 34(6):3831-7. PubMed ID: 23873109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.